The Pharmaceuticals in Dosage Market Size Value Per Capita in Canada has shown notable fluctuations over the past decade. Starting from a value of 1.04 thousand USD per capita in 2012, the market saw a general decline, hitting its lowest at 0.79987 in 2017. Interestingly, there was a recovery phase observed from 2018, with values increasing to 0.92043 in 2019 and 0.92723 in 2020, before peaking at 0.99725 in 2021. By 2022, there was a slight decline to 0.9006 thousand USD per capita. In 2023, the value stood at 0.92 thousand USD per capita.
- Year-on-year variation: The value shows a slight decline of approximately 1.32% from 2021 to 2022.
- Last CAGR (2019-2023): The average annual growth rate over these five years was around 0.23%.
Future trends to watch for include the impact of demographic changes, advancements in pharmaceutical technology, and health policy reforms which could influence market dynamics. Additionally, shifts in global pharmaceutical supply chains and potential post-pandemic healthcare priorities could significantly alter the market landscape in Canada.
| # | 59 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 1,580 | 2023 | View data | ||
| 2 | 2 Germany | 1,460 | 2023 | View data | ||
| 3 | 3 Denmark | 1,300 | 2023 | View data | ||
| 4 | 4 Iceland | 1,220 | 2023 | View data | ||
| 5 | 5 Norway | 1,070 | 2023 | View data | ||
| 9 | 9 United Kingdom | 969.43 | 2023 | View data | ||
| 10 | 10 Spain | 929.61 | 2023 | View data | ||
| 11 | 11 Canada | 909.67 | 2023 | |||
| 12 | 12 Sweden | 902.21 | 2023 | View data | ||
| 13 | 13 Finland | 892.66 | 2023 | View data | ||
